Polio Vaccine Licensed for Use in Novel Approach to Global Eradication Efforts

Sanofi pasteur, the vaccines business of the sanofi-aventis group, has received a license from the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) for a new polio vaccine, which is the first new vaccine developed to fight that disease in decades. The new vaccine -- Monovalent Oral Polio Vaccine 1 or MOPV1 -- will be used first in Egypt as a critical part of a new World Health Organization's strategy to end polio transmission by the end of this year.

Yahoo News (http://biz.yahoo.com/prnews/050331/nyth019.html?.v=3)